Health technology assessment : HTA

The most recent articles from: Health Technol Assess January 2018

Health Technol Assess · Jan 2018

Review Meta Analysis

Axitinib, cabozantinib, everolimus, nivolumab, sunitinib and best supportive care in previously treated renal cell carcinoma: a systematic review and economic evaluation.

Several therapies have recently been approved for use in the NHS for pretreated advanced or metastatic renal cell carcinoma (amRCC), but there is a lack of comparative evidence to guide decisions between them. ⋯ The National Institute for Health Research Health Technology Assessment programme.

read more… or not…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.